Skip to main content
SpringerLink
Log in

The use of adjuvant therapy in patients treated with conservative surgery and radiotherapy

  • Chapter
Adjuvant Therapy of Breast Cancer

Part of the book series: Cancer Treatment and Research ((CTAR,volume 60))

Abstract

Until recently, the critical issue regarding breast-conserving therapy for patients with early-stage invasive breast cancer was whether it could yield survival equal to mastectomy. This has now been demonstrated in several randomized prospective trials [1–5]. As discussed in earlier chapters, the value of adjuvant systemic therapy in the management of at least some subsets of these patients has now been widely accepted. These two developments have resulted in many patients being treated with both breast-conserving therapy and adjuvant systemic therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Veronesi U. Rationale and indications for limited surgery in breast cancer: Current data. World J Surg 11:493–498, 1987.

    Article  PubMed  CAS  Google Scholar 

  2. Sarrazin D, Le MG, Arriagada R, et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 14:177–184, 1989.

    Article  PubMed  CAS  Google Scholar 

  3. Bartelink H and Van Dongen JA. Randomized clinical trial to assess the value of breast conserving therapy (BCT) in Stage I and Stage II breast cancer. Proc 5th Europ Conf Clin Oncol O-854, 1989.

    Google Scholar 

  4. Bader J, Lippman M, Swain S, et al. Preliminary report of the NCI early breast cancer (BC) study: A prospective randomized comparison of lumpectomy (L) and radiation (RT) to mastectomy (M) for Stage I and II BC. Int J Radiat Oncol Biol Phys 13 (Suppl. 1):160, 1987.

    Article  Google Scholar 

  5. Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 320:822–828, 1989.

    Article  PubMed  CAS  Google Scholar 

  6. Harris JR and Hellman S. Conservative Surgery and Radiotherapy, In: Breast Diseases, JR Harris, S Hellman, IC Henderson, and DW Kinne (eds). J.B. Lippincott, Philadelphia, 1987, pp. 299–324.

    Google Scholar 

  7. Recht A and Hayes DF. Specific sites and emergencies: Local recurrence. In: Breast Diseases, JR Harris, S Hellman, IC Henderson, and DW Kinne (eds). J.B. Lippincott, Philadelphia, 1987, pp. 508–524.

    Google Scholar 

  8. Recht A, Silen W, Schnitt SJ, et al. Time-course of local recurrence following conservative surgery and radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys 15:255–261, 1988.

    Article  PubMed  CAS  Google Scholar 

  9. Recht A, Schnitt SJ, Connolly JL, et al. Prognosis following local or regional recurrence after conservative surgery and radiotherapy for early stage breast carcinoma. Int J Radiat Oncol Biol Phys 16:3–9, 1989.

    Article  PubMed  CAS  Google Scholar 

  10. Harris JR and Hellman S. Adjuvant radiotherapy. In: Breast Diseases, JR Harris, S Hellman, IC Henderson, and DW Kinne (eds). J.B. Lippincott, Philadelphia, 1987, pp. 284–299.

    Google Scholar 

  11. Stewart HJ. Scottish adjuvant breast cancer trials: Results in pre-menopausal patients. In: Adjuvant Therapy of Primary Breast Cancer (Recent Results in Cancer Research, Vol. 115), H-J Senn, A Goldhirsch, RD Gelber, and B Osterwalder (eds). Springer-Verlag, Berlin, 1989, pp. 126–131.

    Chapter  Google Scholar 

  12. Stewart HJ, Prescott RJ, and Forrest PA. Conservation therapy of breast cancer (letter). Lancet 2:168–169, 1989.

    Article  PubMed  CAS  Google Scholar 

  13. Levine MN, Gent M, Hryniuk WM, et al. A randomized trial comparing 12 weeks versus 36 weeks of adjuvant chemotherapy in Stage II breast cancer. J Clin Oncol 8:1217–1225, 1990.

    PubMed  CAS  Google Scholar 

  14. Nolvadex Adjuvant Trial Organization. Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. Br J Cancer 57:608–611, 1988.

    Article  Google Scholar 

  15. CRC Adjuvant Breast Trial Working Party. Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancer. Br J Cancer 57:604–607, 1988.

    Article  Google Scholar 

  16. Fornander T, Rutqvist LE, Cedermark B, et al. Adjuvant tamoxifen in early breast cancer: Occurence of new primary tumors. Lancert 1:117–120, 1989.

    Article  CAS  Google Scholar 

  17. Chaudary MA, Doran Z, and Fentiman IS. A randomized trial comparing tumorectomy plus tamoxifen with modified radical mastectomy for elderly patients with operable breast cancer (abstr). Breast Cancer Res Treat 14:137, 1989.

    Google Scholar 

  18. Fisher B, Redmond C, Dimitrov NV, et al. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med 320:473–478, 1989.

    Article  PubMed  CAS  Google Scholar 

  19. Rose MA, Henderson IC, Gelman R, et al. Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure. Int J Radiat Oncol Biol Phys 17:711–717, 1989.

    Article  PubMed  CAS  Google Scholar 

  20. Wazer DE, Tercilla OF, Lin P-S, and Schmidt-Ullrich R. Modulation in the radiosensitivity of MCF-7 human breast carcinoma cells by 17B-estradiol and tamoxifen. Br J Radiol 62:1079–1083, 1989.

    Article  PubMed  CAS  Google Scholar 

  21. Fisher B, Constantino J, Redmond C, et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor positive tumors. N Engl J Med 320:479–484, 1989.

    Article  PubMed  CAS  Google Scholar 

  22. Malaise EP, Charbit A, Chavaudra N, et al. Change in volume of irradiated human metastases: Investigation of repair of sublethal damage and tumor repopulation. Br J Cancer 26:43–52, 1972.

    Article  PubMed  CAS  Google Scholar 

  23. Breur K. Growth rate and radiosensitivity of human tumors — I. Growth rate of human tumors. Eur J Cancer 2:157–171, 1966.

    Article  PubMed  CAS  Google Scholar 

  24. Harris JR and Henderson IC. Natural history and staging of breast cancer. In: Breast Diseases, JR Harris, S Hellman, IC Henderson, and DW Kinne (eds). J.B. Lippincott, Philadelphia, 1987, pp. 233–258.

    Google Scholar 

  25. Clarke DH, Le MG, Sarrazin D, et al. Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: Experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys 11:137–145, 1985.

    Article  PubMed  CAS  Google Scholar 

  26. Nissen-Meyer R, Host H, Kjellgren K, et al. Neoadjuvant chemotherapy in breast cancer: As single perioperative treatment and with supplementary long-term chemotherapy. In: Adjuvant Therapy of Cancer V, SE Salmon (ed). Grune and Stratton, Orlando, FL, 1987, pp. 253–261.

    Google Scholar 

  27. Ludwig Breast Cancer Study Group. Combination adjuvant chemotherapy for node-positive breast cancer: Inadequacy of a single perioperative cycle. N Engl J Med 319:677–683, 1988.

    Article  Google Scholar 

  28. Ludwig Breast Cancer Study Group. Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. N Engl J Med 320:491–496, 1989.

    Article  Google Scholar 

  29. Sertoli MR, Pronzato P, Amoroso D, et al. Perioperative chemotherapy (peri-CT) for primary breast cancer: Preliminary results of a randomized study (abstr). Proc Am Soc Clin Oncol 9:21, 1990.

    Google Scholar 

  30. Marcial VA, Velez-Garcia E, Bartolucci A, et al. Comparison of adjuvant chemotherapy versus local-regional radiotherapy followed by adjuvant chemotherapy in breast cancer patients with 4 or more positive axillary nodes: A Southeastern Cancer Study Group study (abstr). Int J Radiat Oncol Biol Phys 17 (Suppl. 1):180, 1989.

    Article  Google Scholar 

  31. Muss H, Cooper R, Brockschmidt J, et al. A randomized trial of adjuvant chemotherapy (CT) with or without radiation therapy (RT) for stage II breast cancer: 11 year follow-up of Piedmont Oncology Association Protocol 74176 (abstr). Breast Cancer Res Treat 14:185, 1989.

    Google Scholar 

  32. Lara P, Soler M, Asenio C, et al. Combined postoperative radiotherapy and chemotherapy in poor prognosis breast cancer patients: Comparison of three different schedules (abstr). Proc 5th Europ Conf Clin Oncol P-0940, London, 1989.

    Google Scholar 

  33. Brufman G, Sulkes A, and Biran S. Adjuvant chemotherapy with and without radiotherapy in stage II breast cancer. Biomed Pharmacother 42:351–355, 1988.

    PubMed  CAS  Google Scholar 

  34. Brufman G and Sulkes A. A retrospective analysis of adjuvant chemotherapy with and without radiotherapy for stage II breast cancer: A 10-year update (abstr). Proc 5th Europ Conf Clin Oncol P-0882, London, 1989.

    Google Scholar 

  35. Glucksberg H, Rivkin SE, Rasmussen S, et al. Combination chemotherapy (CMFVP) versus 1-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: A Southwest Oncology Group study. Cancer 50:423–434, 1982.

    Article  PubMed  CAS  Google Scholar 

  36. Pronzato P, Campora E, Amoroso D, et al. Impact of administration-related factors on outcome of adjuvant chemotherapy for primary breast cancer. Am J Clin Oncol (CCT) 12:481–485, 1989.

    Article  CAS  Google Scholar 

  37. Taylor SG, Knuiman MW, Sleeper LA, et al. Six-year results of the Eastern Cooperative Oncology Group trial of observation versus CMFP versus CMFPT in postmenopausal patients with node-positive breast cancer. J Clin Oncol 7:879–889, 1989.

    PubMed  Google Scholar 

  38. Buzdar AU, Smith TL, Powell KC, et al. Effect of timing of initiation of adjuvant chemotherapy on disease-free survival in breast cancer. Breast Cancer Res Treat 2:163–169, 1982.

    Article  PubMed  CAS  Google Scholar 

  39. Dalton WS, Brooks RJ, Jones SE, et al. Breast cancer adjuvant therapy trials at the Arizona Cancer Center using adriamycin and cyclophosphamide. In: Adjuvant Therapy of Cancer V, SE Salmon (ed). Grune and Stratton, Orlando, FL, 1987, pp. 263–269.

    Google Scholar 

  40. Gore SM, Come SE, Griem K, et al. Influence of the sequencing of chemotherapy and radiation therapy in node-positive breast cancer patients treated by conservative surgery and radiation therapy. In: Adjuvant Therapy of Cancer V, SE Salmon (ed). Grune and Stratton, Orlando, FL, 1987, pp. 365–373.

    Google Scholar 

  41. Ragaz J, Baird R, and Rebbeck P. Organization of randomized preoperative (neoadjuvant) trial in stage I and II breast cancer — early results (abstr). Proc 2nd Intl Congress on Neo-Adjuvant Chemotherapy, Paris, 1988, p. 9.

    Google Scholar 

  42. Parmentier C, Morardet N, and Tubiana M. Late effects on human bone marrow after extended field radiotherapy. Int J Radiat Oncol Biol Phys 9:1303–1311, 1983.

    Article  PubMed  CAS  Google Scholar 

  43. Rubin P and Scarantino CW. The bone marrow organ: The critical structure in radiation-drug interaction. Int J Radiat Oncol Biol Phys 4:3–23, 1978.

    Article  PubMed  CAS  Google Scholar 

  44. Cristy M. Active bone marrow distribution as a function of age in humans. Phys Med Biol 26:389–400, 1981.

    Article  PubMed  CAS  Google Scholar 

  45. Byfield JE. Hematologic parameters in the adjustment of chemotherapy doses in combined modality treatments involving radiation. Am J Clin Oncol (CCT) 7:371–374, 1984.

    Article  CAS  Google Scholar 

  46. Lippman ME, Lichter AS, Edwards BK, et al. The impact of primary irradiation treatment of localized breast cancer on the ability to administer systemic adjuvant chemotherapy. J Clin Oncol 2:21–27, 1984.

    PubMed  CAS  Google Scholar 

  47. Habibollahi F, Fentiman IS, Chaudary MA, et al. Influence of radiotherapy on the dose of adjuvant chemotherapy in early breast cancer. Breast Cancer Res Treat 13:237–241, 1989.

    Article  PubMed  CAS  Google Scholar 

  48. Holland JF, Glidewell O, and Cooper RG. Adverse effects of radiotherapy on adjuvant chemotherapy for carcinoma of the breast. Surg Gynecol Obstet 150:817–821, 1980.

    PubMed  CAS  Google Scholar 

  49. Levine JF, Coleman CN, Cox RS, et al. The effect of postoperative and primary radiation therapy on delivered dose of adjuvant cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy in breast cancer. Cancer 53:237–241, 1984.

    Article  PubMed  CAS  Google Scholar 

  50. Bonaventura A, Stewart J, Ackland S, et al. Synchronous adjuvant radiotherapy (RT) and chemotherapy (CT) for early breast cancer (abstr). Proc Am Soc Clin Oncol 9:28, 1990.

    Google Scholar 

  51. Botnick LE, Come S, Rose CM, et al. Primary breast irradiation and concomitant adjuvant chemotherapy. In: Conservative Management of Breast Cancer, JR Harris, S Hellman, and W Silen (eds). J.B. Lippincott, Philadelphia, 1983, pp. 321–328.

    Google Scholar 

  52. Weiss RB, Valagussa P, Moliterni A, et al. Adjuvant chemotherapy after conservative surgery plus irradiation versus modified radical mastectomy: Analysis of drug dosing and toxicity. Am J Med 83:455–463, 1987.

    Article  PubMed  CAS  Google Scholar 

  53. Danoff BF, Goodman RL, Glick JH, et al. The effect of adjuvant chemotherapy on cosmesis and complications in patients with breast cancer treated by definitive irradiation. Int J Radiat Oncol Biol Phys 9:1625–1630, 1983.

    Article  PubMed  CAS  Google Scholar 

  54. Glick JH, Fowble BL, Haller DG, et al. Integration of full-dose adjuvant chemotherapy with definitive radiotherapy for primary breast cancer: Four-year update. NCI Monogr 6:297–301, 1988.

    PubMed  Google Scholar 

  55. Hahn P, Hallberg O, and Vikterlof K-J. Acute skin reactions in postoperative breast cancer patients receiving radiotherapy plus adjuvant chemotherapy. Am J Roentgen 130:137–139, 1978.

    CAS  Google Scholar 

  56. Bentzen SO, Overgaard M, Thames HD, et al. Early and late normal-tissue injury after postmastectomy radiotherapy alone or combined with chemotherapy. Int J Radiat Biol 56:711–715, 1989.

    Article  PubMed  CAS  Google Scholar 

  57. Lingos T, Recht A, Vicini F, et al. Radiation pneumonitis in breast cancer pts treated with conservative surgery (CS) and radiation therapy (RT) (abstr). Int J Radiat Oncol Biol Phys 19 (Suppl. 1): 175–176, 1990.

    Google Scholar 

  58. Fowble B, Glick J, and Goodman R. Radiotherapy for the prevention of local-regional recurrence in high risk patients post mastectomy receiving adjuvant chemotherapy. Int J Radiat Oncol Biol Phys 15:627–631, 1988.

    Article  PubMed  CAS  Google Scholar 

  59. Ray GR, Fish VJ, Marmor JB, et al. Impact of adjuvant chemotherapy on cosmesis and complications in stages I and II carcinoma of the breast treated by biopsy and radiation therapy. Int J Radiat Oncol Biol Phys 10:837–841, 1984.

    Article  PubMed  CAS  Google Scholar 

  60. Harris JR and Hellman S. Put the ‘hockey stick’ on ice. Int J Radiat Oncol Biol Phys 15:497–499, 1988.

    Article  PubMed  CAS  Google Scholar 

  61. Pandya KJ, Olson JE, Neuberg D, et al. Observations on cardiac toxicity in a treatment program containing Adriamycin & radiation therapy for Stage III breast cancer: An Eastern Cooperative Oncology Group study (abstr). Breast Cancer Res Treat 14:148, 1989.

    Google Scholar 

  62. Hrafnkelsson J, Nilsson K, and Soderberg M. Tolerance of radiotherapy combined with adjuvant chemotherapy in breast cancer. Acta Oncol 26:269–272, 1987.

    Article  PubMed  CAS  Google Scholar 

  63. Ahmann DL, O’Fallon JR, Scanion PW, et al. A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on the aggressiveness of therapy. Am J Clin Oncol (CCT) 5:371–381, 1982.

    Article  CAS  Google Scholar 

  64. Recht A, Abner A, Vicini F, et al. Regional nodal failure after conservative surgery (CS) & radiotherapy (RT) for early stage breast carcinoma (abstr). Int J Radiat Oncol Biol Phys 19 (Suppl. 1): 130-131, 1990.

    Google Scholar 

  65. Abner A, Recht A, Vicini F, et al. Cosmetic results after conservative surgery, chemotherapy (CTX) and radiation therapy (RT) for early breast cancer (abstr). Int J Radiat Oncol Biol Phys 19 (Suppl. 1):174, 1990.

    Google Scholar 

Download references

Authors
  1. Abram Recht
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel F. Hayes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jay R. Harris
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of California, San Francisco, USA

    I. Craig Henderson

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media New York

About this chapter

Cite this chapter

Recht, A., Hayes, D.F., Harris, J.R. (1992). The use of adjuvant therapy in patients treated with conservative surgery and radiotherapy. In: Henderson, I.C. (eds) Adjuvant Therapy of Breast Cancer. Cancer Treatment and Research, vol 60. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3496-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3496-9_10

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6550-1

  • Online ISBN: 978-1-4615-3496-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation